Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001521536-13-000768
Filing Date
2013-09-13
Accepted
2013-09-12 19:04:30
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 q1101247_10ka-biozone.htm 10-K/A 167710
  Complete submission text file 0001521536-13-000768.txt   168837
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-146182 | Film No.: 131095056
SIC: 2834 Pharmaceutical Preparations